ADAM10 and head and neck squamous cell carcinoma: On the other hand, it has been shown that the activation of hsa-miR-494-3p exhibits a strong ability to reduce cancer stemness in head and neck squamous cell carcinomas by targeting Bmi1 and ADAM10, which correlates with longer survival time (Chang et al., 2015).